The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal.

Determining the long-term effectiveness and costs of regenerative medicines will be associated with considerable uncertainty and potential bias, but existing methods are sufficient to incorporate this uncertainty for decision-making.

http://ift.tt/2lD4Y4t